导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 4.27% | 1247/4773 |
| 近一周 | -1.92% | 890/5462 |
| 近一月 | -2.99% | 1497/5421 |
| 近一季 | -4.66% | 1684/5209 |
| 近半年 | 1.47% | 1044/4920 |
| 近一年 | 9.12% | 1121/4366 |
| 近两年 | 60.01% | 1212/2954 |
| 近三年 | 37.27% | 792/2253 |
| 成立以来 | 642.81% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.00% 2613/4961 |
13.43% 2006/5312 |
- - |
- - |
| 2025 | 28.07% 1509/4813 |
-1.51% 2680/3635 |
4.44% 763/4076 |
22.03% 1710/4524 |
2.02% 1110/4813 |
| 2024 | 12.51% 1239/3463 |
4.83% 428/2808 |
-2.22% 1157/3014 |
14.02% 2057/3129 |
-3.73% 2385/3463 |
| 2023 | -14.74% 1617/2656 |
2.35% 1368/2280 |
-4.84% 1306/2385 |
-4.76% 1216/2515 |
-8.09% 2247/2655 |
| 2022 | -18.04% 653/2207 |
-12.44% 612/1919 |
9.22% 292/2016 |
-12.65% 752/2113 |
-1.88% 1754/2208 |
| 2021 | 1.53% 667/1822 |
-1.94% 555/1255 |
4.34% 897/1330 |
-1.38% 522/1466 |
0.62% 1086/1822 |
| 2020 | 39.99% 319/1250 |
-5.76% 436/1028 |
15.70% 478/1067 |
14.99% 244/1164 |
11.65% 529/1184 |
| 2019 | 34.66% 393/1092 |
19.79% 619/754 |
-0.48% 269/804 |
4.62% 189/850 |
7.96% 376/918 |
| 2018 | -18.61% 148/834 |
- - |
- - |
- - |
-9.80% 163/691 |
| 2017 | 21.71% 161/714 |
- - |
- - |
- - |
- - |
| 2016 | -1.84% 122/605 |
- - |
- - |
- - |
- - |
| 2015 | 19.24% 120/575 |
- - |
- - |
- - |
- - |
| 2014 | 57.87% 43/237 |
- - |
- - |
- - |
- - |
| 2013 | 4.48% 56/186 |
- - |
- - |
- - |
- - |
| 2012 | 3.88% 88/140 |
- - |
- - |
- - |
- - |
| 2011 | -3.35% 1/102 |
- - |
- - |
- - |
- - |
| 2010 | -2.71% 10/58 |
- - |
- - |
- - |
- - |
| 2009 | 11.00% 27/27 |
- - |
- - |
- - |
- - |
| 2008 | -8.80% 1/26 |
- - |
- - |
- - |
- - |
| 2007 | 57.75% 21/22 |
- - |
- - |
- - |
- - |
| 2006 | 27.55% 13/14 |
- - |
- - |
- - |
- - |
| 2005 | -1.46% 4/11 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 申万菱信沪深300指数增强A VS. 长安沪深300非周期A(740101) |